TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32152503 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35851027 — Predictive Biomarker (PRD): LSAMP mRNA
Genes: LSAMP; IGLON3; LAMP
Study 32444457 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34985236 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 35668304 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34185279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32971524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32971524 — Safety Biomarker (SAF): IL-6 and IL-10
Study 35976497 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32333404 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32333404 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34175862 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 36243576 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35357449 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35357449 — Predictive Biomarker (PRD): Microsatellite instability
Study 35257499 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 35257499 — Predictive Biomarker (PRD): TFAM mRNA
Genes: TFAM; TCF6; TCF6L2
Study 35257499 — Predictive Biomarker (PRD): MFN1 mRNA
Genes: MFN1
Study 35257499 — Predictive Biomarker (PRD): DNM1L mRNA
Genes: DNM1L; DLP1; DRP1
Study 35257499 — Predictive Biomarker (PRD): CIDEA mRNA
Genes: CIDEA
Study 33428907 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33428907 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 33616655 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 33616655 — Surrogate Endpoint (SUR): Serum calcium
Study 33616655 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 32647051 — Surrogate Endpoint (SUR): Blood pressure
Study 34848169 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33066786 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33066786 — Surrogate Endpoint (SUR): Blood pressure
Study 33066786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33066786 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32737183 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 33198837 — Surrogate Endpoint (SUR): Blood pressure
Study 34262260 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 34262260 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35997620 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 33564828 — Surrogate Endpoint (SUR): Blood pressure
Study 32907814 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 34390226 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34390226 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34390226 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 34390226 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34174564 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34267120 — Surrogate Endpoint (SUR): Blood pressure
Study 34390228 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34390228 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 33831271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32410379 — Surrogate Endpoint (SUR): Probing pocket depth
Study 36513442 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32224129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34398242 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34398242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32366866 — Pharmacodynamic Biomarker (PDY): Central delta power
Study 35451230 — Predictive Biomarker (PRD): STXBP1 mRNA
Genes: STXBP1; UNC18A
Study 34146594 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34146594 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33832645 — Safety Biomarker (SAF): Hyaluronic acid
Study 34764044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34764044 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33433153 — Surrogate Endpoint (SUR): Blood pressure
Study 32014046 — Surrogate Endpoint (SUR): Blood pressure
Study 33219133 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32875813 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34767967 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 36471691 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32067259 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35087233 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33637064 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 33637064 — Predictive Biomarker (PRD): CASP1 mRNA
Genes: CASP1; IL1BC; IL1BCE
Study 33637064 — Safety Biomarker (SAF): Hyaluronic acid
Study 33637064 — Safety Biomarker (SAF): Interleukin 1
Study 33923868 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 36031523 — Surrogate Endpoint (SUR): Blood pressure
Study 35242206 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 32564645 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 35226737 — Surrogate Endpoint (SUR): Blood pressure
Study 36183850 — Predictive Biomarker (PRD): ROCK2 mRNA
Genes: ROCK2; KIAA0619
Study 36183850 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33031130 — Surrogate Endpoint (SUR): Blood pressure
Study 36067452 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36067452 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36067452 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 36067452 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33285195 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33285195 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32946820 — Surrogate Endpoint (SUR): Blood pressure
Study 34080247 — Surrogate Endpoint (SUR): Blood pressure
Study 34080247 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36153625 — Surrogate Endpoint (SUR): Blood pressure
Study 33289953 — Predictive Biomarker (PRD): ENPP3 mRNA
Genes: ENPP3; PDNP3
Study 35428315 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 35428315 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 36278178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34266452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34266452 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32863329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35611762 — Surrogate Endpoint (SUR): Blood pressure
Study 32175988 — Surrogate Endpoint (SUR): Blood pressure
Study 32611865 — Surrogate Endpoint (SUR): Blood pressure
Study 35553371 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35553371 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 33513650 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 33479025 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36415151 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 34268372 — Safety Biomarker (SAF): Hyaluronic acid
Study 34071714 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34743118 — Safety Biomarker (SAF): Hyaluronic acid
Study 33470741 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32730930 — Predictive Biomarker (PRD): BMP6 mRNA
Genes: BMP6; VGR
Study 35090838 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33964140 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 32623628 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32686050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32686050 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 32686050 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35162507 — Predictive Biomarker (PRD): MBOAT4 mRNA
Genes: MBOAT4; GOAT; OACT4; FKSG89
Study 33462450 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33462450 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 33007918 — Surrogate Endpoint (SUR): Blood pressure
Study 34238838 — Surrogate Endpoint (SUR): Blood pressure
Study 32497217 — Surrogate Endpoint (SUR): Blood pressure
Study 33024271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33024271 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 33024271 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 33024271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 33024271 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34261911 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32145280 — Surrogate Endpoint (SUR): Blood pressure
Study 33507574 — Surrogate Endpoint (SUR): Bone mineral density
Study 33932503 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33949270 — Surrogate Endpoint (SUR): Blood pressure
Study 33957720 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33957720 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 34474581 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34043719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33634382 — Surrogate Endpoint (SUR): Blood pressure
Study 33634382 — Surrogate Endpoint (SUR): Serum triglycerides
Study 33634382 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36383473 — Surrogate Endpoint (SUR): Blood pressure
Study 34280516 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34280516 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34280516 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34280516 — Safety Biomarker (SAF): BDNF
Study 33114210 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33114210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33893836 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34001952 — Predictive Biomarker (PRD): ADIRF mRNA
Genes: ADIRF; AFRO; APM2; C10orf116
Study 34001952 — Predictive Biomarker (PRD): SLC2A5 mRNA
Genes: SLC2A5; GLUT5
Study 34001952 — Predictive Biomarker (PRD): HSPA1B mRNA
Genes: HSPA1B; HSP72
Study 34001952 — Predictive Biomarker (PRD): EEPD1 mRNA
Genes: EEPD1; KIAA1706
Study 33070170 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33070170 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33070170 — Predictive Biomarker (PRD): KLRG1 mRNA
Genes: KLRG1; CLEC15A; MAFA; MAFAL
Study 33588758 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33038079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36145090 — Safety Biomarker (SAF): BDNF
Study 33097279 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33097279 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 33097279 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 33097279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33097279 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33394904 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33394904 — Safety Biomarker (SAF): BDNF
Study 32978449 — Predictive Biomarker (PRD): PLSCR1 mRNA
Genes: PLSCR1
Study 32978449 — Predictive Biomarker (PRD): HCAR1 mRNA
Genes: HCAR1; GPR104; GPR81; HCA1; FKSG80
Study 32447767 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 35395951 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35395951 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33509974 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32366156 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32946280 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 33619948 — Surrogate Endpoint (SUR): Blood pressure
Study 34536265 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32202619 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33559436 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 36078691 — Predictive Biomarker (PRD): ERCC8 mRNA
Genes: ERCC8; CKN1; CSA
Study 36078691 — Predictive Biomarker (PRD): RHOJ mRNA
Genes: RHOJ; ARHJ; RASL7B; RHOI; TCL
Study 32716206 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32716206 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 33722583 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33238677 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 36277012 — Surrogate Endpoint (SUR): Blood pressure
Study 36277012 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 33189876 — Predictive Biomarker (PRD): TRIT1 mRNA
Genes: TRIT1; IPT; MOD5
Study 34930986 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36097559 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32020660 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35419607 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 34867500 — Predictive Biomarker (PRD): FBXO8 mRNA
Genes: FBXO8; FBS; FBX8; DC10; UNQ1877/PRO4320
Study 33230964 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35411169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35411169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35411169 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 35411169 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 33216975 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 35442220 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 36075249 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): miR-124
Study 35982198 — Surrogate Endpoint (SUR): Blood pressure
Study 33186492 — Surrogate Endpoint (SUR): Blood pressure
Study 33186492 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32410922 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 33884972 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35660971 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35660971 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 33068751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 32799042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32799042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32799042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34245292 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 32088207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32088207 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33389521 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 34071293 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35041454 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33368797 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32315287 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33221515 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33221515 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33246338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33246338 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 35278643 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33939289 — Safety Biomarker (SAF): Interleukin 1
Study 34997449 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 35321558 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35020795 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 33471104 — Surrogate Endpoint (SUR): Blood pressure
Study 35815801 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35817742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33793078 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33793078 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33793078 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34588268 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 35617104 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 35617104 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34107730 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 34107730 — Safety Biomarker (SAF): Interleukin 12
Study 32539832 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 32539832 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32539832 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33909260 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33011482 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35524205 — Surrogate Endpoint (SUR): Pathological complete response
Study 34537440 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34537440 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study 34537440 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34537440 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33766695 — Surrogate Endpoint (SUR): Blood pressure
Study 32021141 — Surrogate Endpoint (SUR): Blood pressure
Study 36105248 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36105248 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36530477 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32730948 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 33957621 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33957621 — Surrogate Endpoint (SUR): Blood pressure
Study 33957621 — Surrogate Endpoint (SUR): Serum potassium
Study 32245480 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 32186286 — Surrogate Endpoint (SUR): Probing pocket depth
Study 33179377 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 36003294 — Surrogate Endpoint (SUR): Blood pressure
Study 32779534 — Surrogate Endpoint (SUR): Blood pressure
Study 36224325 — Surrogate Endpoint (SUR): Blood pressure
Study 35816305 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34461803 — Surrogate Endpoint (SUR): Blood pressure
Study 35630063 — Safety Biomarker (SAF): Hyaluronic acid
Study 35630063 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 35648286 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33503656 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 36433863 — Surrogate Endpoint (SUR): Probing pocket depth
Study 36000769 — Predictive Biomarker (PRD): TSN mRNA
Genes: TSN
Study 33477587 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33447966 — Monitoring Biomarker (MOI): Procalcitonin
Study 33447966 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33369329 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 33184931 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36243220 — Surrogate Endpoint (SUR): Bone mineral density
Study 32323609 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33310801 — Surrogate Endpoint (SUR): Blood pressure
Study 35043556 — Surrogate Endpoint (SUR): Blood pressure
Study 33826132 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3